There are currently 65 clinical trials in Webster, Texas looking for participants to engage in research studies. Trials are conducted at various facilities, including Center for Clinical Studies, Center for Clinical Studies, LTD. LLP, Center of Reproductive Medicine and Tranquil Clinical Research. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA
Recruiting
This study will confirm the ability of Tc 99m tilmanocept imaging to predict clinical response in individuals with RA who are beginning anti-TNFα therapy.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/31/2023
Locations: Tranquil Clinical Research, Webster, Texas
Conditions: Rheumatoid Arthritis
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
Recruiting
DMX-200 (repagermanium) is a C-C chemokine receptor type 2 (CCR2) inhibitor that, when administered concurrently with an ARB, is designed to inhibit recruitment of monocytes implicated in the inflammatory chemokine environment of chronic disease. The purpose of this pivotal randomized double-blind study is to investigate the efficacy and safety of DMX-200 120 mg twice daily (BID) compared with placebo over a treatment period of 104 weeks in adult patients with FSGS who are being treated with an... Read More
Gender:
All
Ages:
Between 12 years and 80 years
Trial Updated:
10/24/2023
Locations: ACTION3 Investigational Site 16, Webster, Texas
Conditions: FSGS
XTX101 Monotherapy and XTX101 and Atezolizumab Combination Therapy in Patients With Advanced Solid Tumors
Recruiting
This is a first-in-human, Phase 1/2, multicenter, open-label study designed to evaluate the safety and tolerability of XTX101 as monotherapy and XTX101 and atezolizumab combination therapy in patients with advanced solid tumors.
Gender:
All
Ages:
18 years and above
Trial Updated:
08/24/2023
Locations: Tranquil Clinical Research, Webster, Texas
Conditions: Advanced Solid Tumor
Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis
Recruiting
The purpose of this study is to evaluate the safety and tolerability of XmAb27564 following multiple doses among participants with plaque psoriasis and atopic dermatitis.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
08/22/2023
Locations: Center for Clinical Studies, LTD. LLP, Webster, Texas
Conditions: Psoriasis, Atopic Dermatitis
A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma
Recruiting
This study will be a multicenter, prospective, open label, one-arm study intended to assess the Safety and Efficacy of EscharEx (EX-02) in the treatment of Basal Cell Carcinoma. In patients with one primary superficial or nodular basal cell carcinoma lesion with a diameter of 5-10mm (Histologically confirmed BCC) located on the trunk or upper extremities (not including the hands), with well-defined borders and no previous radiation therapy.
Gender:
All
Ages:
18 years and above
Trial Updated:
12/01/2021
Locations: Center for Clinical Studies, LTD. LLP, Webster, Texas
Conditions: Superficial Basal Cell Carcinoma, Nodular Basal Cell Carcinoma